Diagnos Inc.
DGNOF
$0.16
$0.002.17%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.60% | 3.90% | -6.50% | -53.64% | -55.33% |
| Total Depreciation and Amortization | -8.68% | 3.83% | 4.66% | 4.31% | -6.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.49% | -26.32% | 15.65% | -6.81% | -27.79% |
| Change in Net Operating Assets | -155.69% | 156.13% | -90.56% | 103.68% | -215.12% |
| Cash from Operations | 1.77% | 22.69% | -51.93% | -16.82% | -124.57% |
| Capital Expenditure | -11.76% | 83.33% | 48.08% | -- | -21.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 513.38% | -271.35% | 186.89% | 419.90% | -266.92% |
| Cash from Investing | 509.74% | -269.37% | 186.24% | 419.13% | -269.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 45.67% | -4.28% | -268.52% | -1,424.81% | -553.63% |
| Issuance of Common Stock | -- | 133.70% | -- | -- | 250.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.17% | 40.13% | 4.71% | 4.89% | 17.35% |
| Cash from Financing | -119.39% | 147.72% | -104.62% | -156.84% | 245.60% |
| Foreign Exchange rate Adjustments | 150.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -581.10% | 77.19% | 4.20% | 135.86% | -84.95% |